Association of polymorphism in pri-microRNAs-371-372-373 with the occurrence of hepatocellular carcinoma in hepatitis B virus infected patients

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Kwak, Min Sun ^a   Lee, Dong Hyeon ^a   Cho, Yuri ^a   Cho, Eun Ju ^a   Lee, Jeong Hoon ^a   Yu, Su Jong ^a   Yoon, Jung Hwan ^a   Lee, Hyo Suk ^a   Kim, Chung Yong ^a   Cheong, Jae Youn ^b   Cho, Sung Won ^b   Shin, Hyoung Doo ^c   Kim, Yoon Jun ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c Sogang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 371; MICRORNA 372; MICRORNA 373; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CANCER INCIDENCE; CANCER RISK; DISEASE SEVERITY; DNA SEQUENCE; ETHNIC GROUP; FEMALE; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HETEROZYGOTE; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; VIRAL CLEARANCE; VIRUS CARRIER;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 84864397029     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041983     Document Type: Article

References (44)

1. Lok AS, McMahon BJ, ((2007)) Chronic hepatitis B. Hepatology 45:: 507--539.
2. Ganem D, Prince AM, ((2004)) Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 350:: 1118--1129.
3. Brunetto MR, Rodriguez UA, Bonino F, ((1999)) Hepatitis B virus mutants. Intervirology 42:: 69--80.
4. Koziel MJ, ((1998)) The immunopathogenesis of HBV infection. Antivir Ther 3:: 13--24.
5. Ito K, Arai M, Imazeki F, Yonemitsu Y, Bekku D, et al. ((2010)) Risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Scand J Gastroenterol 45:: 243--249.
6. Turati F, Edefonti V, Talamini R, Ferraroni M, Malvezzi M, et al. ((2012)) Family history of liver cancer and hepatocellular carcinoma. Hepatology 55:: 1416--1425.
7. Yu MW, Chang HC, Liaw YF, Lin SM, Lee SD, et al. ((2000)) Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. J Natl Cancer Inst 92:: 1159--1164.
8. Jung YJ, Kim YJ, Kim LH, Lee SO, Park BL, et al. ((2007)) Putative association of Fas and FasL gene polymorphisms with clinical outcomes of hepatitis B virus infection. Intervirology 50:: 369--376.
9. Bae JS, Pasaje CF, Park BL, Cheong HS, Kim JH, et al. ((2011)) Genetic analysis of complement component 9 (C9) polymorphisms with clearance of hepatitis B virus infection. Dig Dis Sci 56:: 2735--2741.
10. Kim JH, Yu SJ, Park BL, Cheong HS, Pasaje CF, et al. ((2011)) TGFBR3 polymorphisms and its haplotypes associated with chronic hepatitis B virus infection and age of hepatocellular carcinoma occurrence. Dig Dis 29:: 278--283.
11. Park BL, Kim YJ, Cheong HS, Lee SO, Han CS, et al. ((2007)) HDAC10 promoter polymorphism associated with development of HCC among chronic HBV patients. Biochem Biophys Res Commun 363:: 776--781.
12. Park TJ, Chun JY, Bae JS, Park BL, Cheong HS, et al. ((2010)) CCND2 polymorphisms associated with clearance of HBV infection. J Hum Genet 55:: 416--420.
13. Guo H, Ingolia NT, Weissman JS, Bartel DP, ((2010)) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466:: 835--840.
14. Bartel DP, ((2004)) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:: 281--297.
15. Ambros V, ((2004)) The functions of animal microRNAs. Nature 431:: 350--355.
16. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. ((2005)) MicroRNA expression profiles classify human cancers. Nature 435:: 834--838.
17. Munker R, Calin GA, ((2011)) MicroRNA profiling in cancer. Clin Sci (Lond) 121:: 141--158.
18. Tang JT, Wang JL, Du W, Hong J, Zhao SL, et al. ((2011)) MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer. Carcinogenesis 32:: 1207--1215.
19. Christensen BC, Avissar-Whiting M, Ouellet LG, Butler RA, Nelson HH, et al. ((2010)) Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer. Clin Cancer Res 16:: 3713--3720.
20. Song F, Zheng H, Liu B, Wei S, Dai H, et al. ((2009)) An miR-502-binding site single-nucleotide polymorphism in the 3′-untranslated region of the SET8 gene is associated with early age of breast cancer onset. Clin Cancer Res 15:: 6292--6300.
21. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, et al. ((2007)) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133:: 647--658.
22. Jiang J, Gusev Y, Aderca I, Mettler TA, Nagorney DM, et al. ((2008)) Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 14:: 419--427.
23. Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, et al. ((2006)) Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 25:: 2537--2545.
24. Hou J, Lin L, Zhou W, Wang Z, Ding G, et al. ((2011)) Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 19:: 232--243.
25. Guo H, Liu H, Mitchelson K, Rao H, Luo M, et al. ((2011)) MicroRNAs-372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B. Hepatology 54:: 808--819.
26. Bruix J, Sherman M, ((2011)) Management of hepatocellular carcinoma: an update. Hepatology 53:: 1020--1022.
27. Suk KT, Baik SK, Yoon JH, Cheong JY, Paik YH, et al. ((2012)) Revision and update on clinical practice guideline for liver cirrhosis. Korean J Hepatol 18:: 1--21.
28. Livak KJ, ((1999)) Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 14:: 143--149.
29. Stephens M, Smith NJ, Donnelly P, ((2001)) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:: 978--989.
30. Barrett JC, Fry B, Maller J, Daly MJ, ((2005)) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:: 263--265.
31. Zhang LS, Liang WB, Gao LB, Li HY, Li LJ, et al. ((2012)) Association Between pri-miR-218 Polymorphism and Risk of Hepatocellular Carcinoma in a Han Chinese Population. DNA Cell Biol 31:: 761--765.
32. Harnprasopwat R, Ha D, Toyoshima T, Lodish H, Tojo A, et al. ((2010)) Alteration of processing induced by a single nucleotide polymorphism in pri-miR-126. Biochem Biophys Res Commun 399:: 117--122.
33. Akkiz H, Bayram S, Bekar A, Akgollu E, Ulger Y, ((2011)) A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study. J Viral Hepat 18:: e399--407.
34. Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, et al. ((2006)) A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124:: 1169--1181.
35. Cairo S, Wang Y, de Reynies A, Duroure K, Dahan J, et al. ((2010)) Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer. Proc Natl Acad Sci U S A 107:: 20471--20476.
36. Bandres E, Cubedo E, Agirre X, Malumbres R, Zarate R, et al. ((2006)) Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 5:: 29.
37. Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, et al. ((2008)) The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 10:: 202--210.
38. Zhou AD, Diao LT, Xu H, Xiao ZD, Li JH, et al. ((2012)) beta-Catenin/LEF1 transactivates the microRNA-371-373 cluster that modulates the Wnt/beta-catenin-signaling pathway. Oncogene 31:: 2968--2978.
39. Kudo M, ((2011)) Molecular targeted therapy for hepatocellular carcinoma: bench to bedside. Dig Dis 29:: 273--277.
40. Tommasi S, Pinto R, Pilato B, Paradiso A, ((2007)) Molecular pathways and related target therapies in liver carcinoma. Curr Pharm Des 13:: 3279--3287.
41. Wang S, Qiu L, Yan X, Jin W, Wang Y, et al. ((2012)) Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1)-modulated P53 activity. Hepatology 55:: 730--741.
42. Chen Y, Shen A, Rider PJ, Yu Y, Wu K, et al. ((2011)) A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication. FASEB J 25:: 4511--4521.
43. Feitelson MA, Lee J, ((2007)) Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. Cancer Lett 252:: 157--170.
44. Kim H, Jee YM, Song BC, Shin JW, Yang SH, et al. ((2007)) Molecular epidemiology of hepatitis B virus (HBV) genotypes and serotypes in patients with chronic HBV infection in Korea. Intervirology 50:: 52--57.